Welcome to Industry Focus, the podcast that dives into a different sector of the stock market every day.

I'm your host Christine Harjus and today I'll be talking health care with my usual partner in crime, Todd.

Todd, how are you doing today?

I am doing well.

Christine, you sound like you might have a little bit of a cold.

I know.

I'm not really sure what this is.

It is full-blown allergy season here in DC, so I'm hoping it's allergies, but apologies to listeners because I know I don't sound great.

Well, hopefully you'll feel better soon.

Yeah, I hope so, fingers crossed. and also I apologize in advance if I end up

coughing or something during this episode. I'm going to try really hard not to. I've got my

water next to me and we'll see how it goes. Excellent, all right.

So today we are talking about just one topic,

which I feel like is kind of unusual for our healthcare show.

We usually like to pack a bunch of different things in,

but we are focusing on the largest

pharmaceutical company in the world, which is Johnson and Johnson.

This company is so big that it almost feels like when you're, although we're

covering one subject, we're really covering

like eight subjects, right?

I mean, if we really want to make ourselves sound impressive, we are covering the 250-plus

sub-companies in the Johnson and Johnson family of companies.

...